Dube Michael P 4
4 · Intellia Therapeutics, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Dube Michael P
VP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-07-02$9.95/sh−2,503$24,905→ 57,137 total
Footnotes (1)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 1, 2025, and does not represent a volitional trade by the Reporting Person.